{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:53:41Z","timestamp":1792896821547,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.nucmedbio.2016.08.010","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T21:23:58Z","timestamp":1472160238000},"page":"773-780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["[ 18 F]MEL050 as a melanin-targeted PET tracer: Fully automated radiosynthesis and comparison to  18 F-FDG for the detection of pigmented melanoma in mice primary subcutaneous tumors and pulmonary metastases"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7089-1908","authenticated-orcid":false,"given":"Nathalie","family":"Rizzo-Padoin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chaussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Vignal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Kotula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Tsoupko-Sitnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortune","family":"Hontonnou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Poyet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Merlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Hosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Sarda-Mantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics","volume":"59","author":"Jemal","year":"2009","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bjd.12492","article-title":"Emerging trends in the epidemiology of melanoma","volume":"170","author":"Nikolaou","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics","volume":"58","author":"Jemal","year":"2008","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.critrevonc.2009.08.005","article-title":"Treatment for metastatic malignant melanoma: old drugs and new strategies","volume":"74","author":"Mouawad","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0035","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrclinonc.2013.83","article-title":"Paradoxical oncogenesis--the long-term effects of BRAF inhibition in melanoma","volume":"10","author":"Gibney","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/OTT.S57335","article-title":"Ipilimumab in the treatment of metastatic melanoma: management of adverse events","volume":"7","author":"Della Vittoria Scarpati","year":"2014","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0045","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1586\/era.11.25","article-title":"Therapy for metastatic melanoma: an overview and update","volume":"11","author":"Boyle","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.sder.2010.11.002","article-title":"Sentinel node biopsy for melanoma: an update after two decades of experience","volume":"29","author":"Ross","year":"2010","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0055","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00259-015-3187-2","article-title":"Influence of (18)F-FDG PET\/CT on therapy management in patients with stage III\/IV malignant melanoma","volume":"43","author":"Sch\u00fcle","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0060","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1021\/jm991079p","article-title":"Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization","volume":"43","author":"Eisenhut","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0065","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1021\/jm701424g","article-title":"Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma","volume":"51","author":"Chezal","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0070","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2174\/092986709788612684","article-title":"Benzamides as melanotropic carriers for radioisotopes, metals, cytotoxic agents and as enzyme inhibitors","volume":"16","author":"Oltmanns","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0075","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1021\/jm101574q","article-title":"Single photon emission computed tomography\/positron emission tomography imaging and targeted radionuclide therapy of melanoma: new multimodal fluorinated and iodinated radiotracers","volume":"54","author":"Maisonial","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1034\/j.1600-0420.1998.760110.x","article-title":"Clinical study of [123I]N-(2-diethylaminoethyl)-4-iodobenzamide in the diagnosis of primary and metastatic ocular melanoma","volume":"76","author":"Bacin","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0085","first-page":"34","article-title":"Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma","volume":"27","author":"Sillaire-Houtmann","year":"2004"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2967\/jnumed.113.123554","article-title":"123I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial","volume":"55","author":"Cachin","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0095","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2967\/jnumed.109.070060","article-title":"High-contrast PET of melanoma using 18F-MEL050, a selective probe for melanin with predominantly renal clearance","volume":"51","author":"Denoyer","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2967\/jnumed.110.078154","article-title":"Improved detection of regional melanoma metastasis using 18F-6-Fluoro-N-[2-(diethylamino)ethyl] pyridine-3-Carboxamide, a melanin-specific PET probe, by Perilesional administration","volume":"52","author":"Denoyer","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0105","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00259-012-2168-y","article-title":"Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [18F]ICF01006, a highly promising melanoma PET tracer","volume":"39","author":"Rbah-Vidal","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0110","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1021\/jm9008423","article-title":"Discovery of [18F]N-(2-(diethylamino)ethyl)-6-fluoronicotinamide: a melanoma positron emission tomography imaging radiotracer with high tumor to body contrast ratio and rapid renal clearance","volume":"52","author":"Greguric","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0115","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1071\/CH11048","article-title":"Radiosynthesis of a novel PET fluoronicotinamide for melanoma tumour PET imaging; [18F]MEL050","volume":"64","author":"Greguric","year":"2011","journal-title":"Aust J Chem"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0120","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1038\/nprot.2014.137","article-title":"Optimization of nucleophilic 18F radiofluorinations using a microfluidic reaction approach","volume":"9","author":"Pascali","year":"2014","journal-title":"Nat Protoc"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0125","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1021\/jm400877v","article-title":"Synthesis, Radiofluorination, and in vivo evaluation of novel fluorinated and iodinated radiotracers for PET imaging and targeted radionuclide therapy of melanoma","volume":"56","author":"Billaud","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0130","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejmech.2015.01.034","article-title":"Synthesis, radiolabeling and preliminary in vivo evaluation of multimodal radiotracers for PET imaging and targeted radionuclide therapy of pigmented melanoma","volume":"92","author":"Billaud","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0135","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ejmech.2012.11.047","article-title":"Synthesis, radioiodination and in vivo screening of novel potent iodinated and fluorinated radiotracers as melanoma imaging and therapeutic probes","volume":"63","author":"Maisonial","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.nucmedbio.2016.08.010_bb0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.nucmedbio.2005.04.006","article-title":"Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation","volume":"32","author":"Mansard","year":"2005","journal-title":"Nucl Med Biol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805116301706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805116301706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,15]],"date-time":"2018-07-15T00:48:03Z","timestamp":1531615683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805116301706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0969805116301706"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.08.010","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[18F]MEL050 as a melanin-targeted PET tracer: Fully automated radiosynthesis and comparison to 18F-FDG for the detection of pigmented melanoma in mice primary subcutaneous tumors and pulmonary metastases","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}